Overview
Corentin Spriet practices in Lille, France. Mr. Spriet is rated as an Advanced expert by MediFind in the treatment of TMEM165-CDG. His top areas of expertise are TMEM165-CDG, Brain Stem Cancer, Prostate Cancer, and Diffuse Midline Glioma H3 K27M-Mutant.
His clinical research consists of co-authoring 50 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of TMEM165-CDG.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- TMEM165-CDGMr. Spriet isAdvanced. Learn about TMEM165-CDG.
- Experienced
- Brain Stem CancerMr. Spriet isExperienced. Learn about Brain Stem Cancer.
- Diffuse Midline Glioma H3 K27M-MutantMr. Spriet isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.
- Prostate CancerMr. Spriet isExperienced. Learn about Prostate Cancer.